North America Ureteral Stents Market

North America Ureteral Stents Market Size (2023 to 2028):

The size of the North America Ureteral Stents Market was valued at USD 135.09 Million in 2023 and is expected to reach USD 186.39 Million by 2028, forecasted to hike at a promising rate of 6.65% from 2023 to 2028.

High occurrence of urinary tract infections and high acquisition of ureteral stents stimulates the growth in the market. Nearly 92,000 stent surgeries are performed every year in the U.S., according to the study published by Urology in 2018. The rise in the elder people population, as the age grows, the menace of obtaining the urinary tract infection is at equality, and the standard rate is double in people who are 65 years and above aged women are considered to have a positive impact in the growth. The urinary tract infection in adult women is approximately 50%-60% globally. According to the National Center for Biotechnology Information report, the U.S. kidney stone problem affects 1 in 11 individuals, and is forecasted around 600,000 Americans suffer from kidney stones every year.

Usage of urinary stents in the body may cause infections; dislocation, blockage, and rise in urination oscillation are significant factors hindering the market. The pressuring price of the treatment of urinary stents is so high where ordinary people can’t afford to impede the growth.

This research report on the North America Ureteral Stents Market has been segmented and sub-segmented into the following categories:

By Type:

• Expandable Stent
• Double pigtail stent (JJ Stent))

By Patients Sex:

• Male
• Female

By End User:

• Hospital
• Clinical

By Medical Situation:

• Kidney Stones
• Kidney Failures
• Tumors

By Country:

• The United States
• Canada
• Rest of North America

Regional Analysis:

North America is to dominate the market with the largest share in the period globally due to adequate medical services, and the growing occurrence rate of kidney diseases is fueling the growth. The region is expected to witness excessive growth due to improved healthcare infrastructure acquiring new techniques and procedures, increasing the population of diabetic patients, which accelerates the market growth in the region. Side-affects rise with the stents' usage, and the clearance obstacles remain as a bottleneck in the market growth. Increasing population base and growing inactive lifestyles, and increasing kidney transplantations are likely to boost the market. A growing number of kidney transplants are driving the market. According to the National Kidney Foundation submitted, around 121,678 people were waiting for lifesaving organ transplants in the U.S. in 2016. Canada is expected to witness promising growth in the region due to a rise in funds by the government sectors and different key players to develop healthcare infrastructure.

Prominent Companies dominating the North America Ureteral Stents Market Profiled in the Report are UteraC. R. Bard, Inc., Penn Medical, Cook Medical Inc., Boston Scientific Corporation, and Medline Industries, Inc.